ARTICLE | Clinical News
CDP571: Completed patient recruitment for a Phase II U.K. study
May 23, 1994 7:00 AM UTC
Celltech Group plc (U.K.) Product: CDP571 human anti-TNF antibody Indication: Rheumatoid arthritis Status: Completed patient recruitment for a Phase II U.K. study in 36 patients with severe rheumatoid...